Vedolizumab Achieves Corticosteroid-Free Clinical Response and Remission in Inflammatory Bowel Disease: A Real World Meta-Analysis

被引：0
|
作者：
Shaw, Caroline [1 ]
Brown, Rebecca [1 ]
Wang, Song [2 ]
Adsul, Shashi [3 ]
Agboton, Christian [3 ]
Kamble, Pravin [2 ]
机构：
[1] PHMR, London, England
[2] Takeda, Cambridge, MA USA
[3] Takeda, Zurich, Switzerland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0688
引用
收藏
页码：S345 / S345
页数：1
相关论文
共 50 条
  • [21] Corticosteroid-Free Remission in Anti-TNF-Failed Crohn's Disease Patients Treated With Vedolizumab as Second-Line Biologic Therapy: A Real World Data Review
    Agboton, Christian
    Lindner, Dirk
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S895 - S896
  • [22] Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease
    Kotze, Paulo G.
    Ma, Christopher
    Almutairdi, Abdulelah
    Al-Darmaki, Ahmed
    Devlin, Shane M.
    Kaplan, GilaadG.
    Seow, Cynthia H.
    Novak, Kerri L.
    Lu, Cathy
    Ferraz, Jose G. P.
    Stewart, Michael J.
    Buresi, Michelle
    Jijon, Humberto
    Mathivanan, Meena
    Heatherington, Joan
    Martin, Marie-Louise
    Panaccione, Remo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 626 - 637
  • [23] EARLY VEDOLIZUMAB TROUGH LEVELS PREDICT CLINICAL RESPONSE IN A "REAL WORLD" PROSPECTIVE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
    Bonthala, Nirupama
    Morganstern, Bradley
    Mengesha, Emebet
    Landers, Carol
    Mould, Diane R.
    Li, Dalin
    Vasiliauskas, Eric
    Targan, Stephan R.
    McGovern, Dermot P. B.
    Melmed, Gil
    GASTROENTEROLOGY, 2020, 158 (06) : S465 - S466
  • [24] Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab
    Christensen, Britt
    Rubin, David T.
    Goeppinger, Sarah
    Colman, Ruben J.
    Yarur, Andres
    Hirsch, Ayal
    Bocheneck, Ashley
    Wichmann, Alana
    Sakuraba, Atsushi
    Cohen, Russell
    Siddiqui, Dania
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S783 - S784
  • [25] Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease for patients in histological remission
    Blad, William
    Whitley, Lisa
    Harrow, Paul
    GUT, 2023, 72 (SUPPL_2) : A87 - A88
  • [26] SUSTAINED CORTICOSTEROID-FREE REMISSION WITH VEDOLIZUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS: A POST HOC ANALYSIS OF GEMINI 1
    Loftus, Edward V.
    Sands, Bruce E.
    Colombel, Jean Frederic
    Dotan, Iris
    Khalid, Javaria M.
    Tudor, David
    Geransar, Parnia
    GASTROENTEROLOGY, 2018, 154 (06) : S390 - S390
  • [27] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, Fabio Salvatore
    Ventimiglia, Marco
    Orlando, Ambrogio
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1217 - 1227
  • [28] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, F. S.
    Ventimiglia, M.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 857 - 858
  • [29] Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes
    Sgourakis, George
    Radtke, Arnold
    Fouzas, Ioannis
    Mylona, Sofia
    Goumas, Kostantinos
    Gockel, Ines
    Lang, Hauke
    Karaliotas, Constantine
    TRANSPLANT INTERNATIONAL, 2009, 22 (09) : 892 - 905
  • [30] Sustained corticosteroid-free remission with vedolizumab in moderate-to-severe ulcerative colitis: A post hoc analysis of GEMINI 1
    Loftus, E. V.
    Sands, B. E.
    Colombel, J. -F.
    Dotan, I.
    Khalid, J. M.
    Tudor, D.
    Geransar, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S317 - S318
12345